First Time Loading...

Fate Therapeutics Inc
NASDAQ:FATE

Watchlist Manager
Fate Therapeutics Inc Logo
Fate Therapeutics Inc
NASDAQ:FATE
Watchlist
Price: 3.51 USD -0.28%
Updated: May 28, 2024
FATE
/
Cash Flow Statement
/
Change in Working Capital

Fate Therapeutics Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fate Therapeutics Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Fate Therapeutics Inc
NASDAQ:FATE
Change in Working Capital
$3.6m
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
11%
Abbvie Inc
NYSE:ABBV
Change in Working Capital
$3.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
38%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$2.2B
CAGR 3-Years
-33%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$422m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$275.3m
CAGR 3-Years
-158%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
$105.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Fate Therapeutics Inc's Change in Working Capital?
Change in Working Capital
3.6m USD

Based on the financial report for Mar 31, 2024, Fate Therapeutics Inc's Change in Working Capital amounts to 3.6m USD.

What is Fate Therapeutics Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
11%

ALPHA SPREAD
Join more than 141,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.